Where next for behavioral public policy?


Journal

The Behavioral and brain sciences
ISSN: 1469-1825
Titre abrégé: Behav Brain Sci
Pays: England
ID NLM: 7808666

Informations de publication

Date de publication:
30 08 2023
Historique:
medline: 31 8 2023
pubmed: 30 8 2023
entrez: 30 8 2023
Statut: epublish

Résumé

Our target article distinguishes between policy approaches that seek to address societal problems through intervention at the level of the individual (adopting the "i-frame") and those that seek to change the system within which those individuals live (adopting the "s-frame"). We stress also that a long-standing tactic of corporations opposing systemic change is to promote the i-frame perspective, presumably hoping that i-frame interventions will be largely ineffective and more importantly will be seen by the public and some policy makers as a genuine alternative to systemic change. We worry that the i-frame focus of much of behavioral science has inadvertently reinforced this unhelpful focus on the individual. In this response to commentators, we identify common themes, build on the many constructive suggestions to extend our approach, and reply to concerns. We argue, along with several commentators, that a key role of behavioral public policy is to clarify how to build support for systemic reforms for which there is a broad consensus in the policy community, but which are opposed by powerful special interests.

Identifiants

pubmed: 37646288
doi: 10.1017/S0140525X23002091
pii: S0140525X23002091
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

e181

Commentaires et corrections

Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn
Type : CommentOn

Auteurs

Nick Chater (N)

Behavioural Science Group, Warwick Business School, University of Warwick, Coventry, UK nick.chater@wbs.ac.uk; https://www.wbs.ac.uk/about/person/nick-chater/.

George Loewenstein (G)

Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, PA, USA gl20@andrew.cmu.edu; https://www.cmu.edu/dietrich/sds/people/faculty/george-loewenstein.html.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH